Broad assay menu. Optimal performance.
Powered by the Atellica Solution for chemistry and immunoassay results you can count on.

Broad assay menu. Optimal performance.
 
Contact Us

Over 175 assays for a complete disease-state picture

  • Provides the latest innovations in assay development, including High-Sensitivity Troponin I and PCT assays
  • Offers flexibility to meet testing needs for today and in the future with over 40 assays in development
  • Delivers fast, accurate results across disease states all consolidated on a single platform.

Get the full menu now 0.2 MB

TnIH


TnIH

A 10-minute high-sensitivity troponin I assay (TnIH) for improved cardiac patient care

  • A true high-sensitivity troponin I assay that meets the current guideline recommendations
  • Greater level of sensitivity and precision at the low end of the measuring range provides the ability to measure slight, yet critical changes between serial troponin I values
  • Helps clinicians quickly and confidently triage chest pain patients

Learn more about the High-Sensitivity Troponin I (TnIH) Assay now

PCT


PCT

Atellica® IM B·R·A·H·M·S Procalcitonin (PCT) Assay for fast sepsis diagnosis

  • Helps achieve earlier sepsis diagnosis and risk assessment to help improve patient outcomes— with high low-end sensitivity, the assay aids in the ability to make confident decisions in minutes
  • Helps provide confidence when guiding antibiotic therapy with an assay that has optimal precision across the measurable range
  • Helps deliver reliable results from a proven, trusted technology that demonstrates high agreement with the B·R·A·H·M·S PCT sensitive KRYPTOR assay

Get the whitepaper now

Infectious Disease Assays


Infectious Disease Assays

Comprehensive menu for early detection of infectious diseases

  • Provides testing accuracy with disposable sample tips that are intended to eliminate sample cross-contamination
  • Aids in better patient outcomes with assays such as HBsAg II, CHIV*, HCV, and syphilis, designed for high sensitivity, precision, and accuracy
  • Improves efficiency using the HBsAg SMART algorithm and the hot zone, which helps reduce repeat testing and reduces turnaround time

Clinical Performance of Two Fourth-Generation HIV Assays 0.1 MB

Performance Evaluation of the Atellica IM HIV Ag/A Combo (CHIV) and HIV 1/0/2 Enhanced (EHIV) Assays* 0.3 MB

Revolutionary STAT capabilities


Revolutionary STAT capabilities

Powerful assays fueled by the Atellica Solution—flexible, scalable, automation-ready immunoassay and chemistry analyzers with revolutionary STAT capabilities to deliver fast, actionable, reliable results

  • STAT samples consistently aspirated within 60 seconds of the first barcode read
  • Bidirectional high-speed Atellica Magline® Transport allows STAT samples to bypass routine samples
  • Independent control over every sample for consistent, predictable turnaround time


Get the sample management whitepaper now

Complete the form below to speak to a sales representative.



Because of some maintenance activities, this service is not available currently.
Please try again later.

An issue occurred on this form. Either, one or more missing and/or incorrect entries are in the form. Each is underlined in red. Or, the data inserted by you seems to be invalid. Please check if you filled in all form fields as expected according to the field names (e.g. ‘First Name’, ‘Last Name’ etc.). Please correct and re-submit your request again. Thank you!

An issue occurred on this form. The data inserted by you seems to be invalid. Please check if you filled in all form fields as expected according to the field names (e.g. ‘First Name’, ‘Last Name’ etc.). Please correct and re-submit your request again. Thank you!

* Required

Thank you for getting in touch. Please anticipate a response in 3-5 working days.

To keep up to date with Siemens Healthineers news and events specific to your interest area, sign up for Siemens Healthineers eNews and choose your individualised preferences.

Due to technical reasons your request cannot be completed. Please try again or contact us. We apologize for the inconvenience caused.


Share this page: